All companies
Visit website
CaryRx
OperatingCary Rx Inc
Tech Enabled, On-Demand Pharmacy with Free Same-Day Delivery
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$137,415
Across 1 round since 2018
Latest share price
$1.00
Reg CF Offering (2018) offering price
Financials
FY2016–FY2017 · from SEC filings · hover any figure for its source$0
−$53K
2016
$59K
−$137K
2017
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016
FY2017
Income statement
Revenue
$0
$58,646
Cost of goods sold
$0
$57,209
Gross margin
—
2%
Net income
-$53,209
-$137,476
Taxes paid
$175
$475
Balance sheet
Cash
-$628
$15,950
Accounts receivable
$0
$0
Total assets
$66,884
$156,075
Short-term debt
$11,068
$119,224
Long-term debt
$45,676
$161,375
Total liabilities
$56,744
$280,599
Other
Headcount
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Fundraising history
Raised $137.4K / $1.1MInvestors 158
Reg CF annual-report compliance
Delinquent
Filed 0 of 8 annual reports (FY2018–FY2025)
Missing: 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025
158 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001757903Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.